Review



sureselect clinical research exome v.2 kit  (Agilent technologies)


Bioz Verified Symbol Agilent technologies is a verified supplier
Bioz Manufacturer Symbol Agilent technologies manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Agilent technologies sureselect clinical research exome v.2 kit
    Sureselect Clinical Research Exome V.2 Kit, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sureselect+clinical+research+exome+v%2E2+kit/med_rxiv__2024__08__08__24311713-27-15-21
    Average 90 stars, based on 1 article reviews
    sureselect clinical research exome v.2 kit - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Sequencing:

    Article Title: Adenomas from individuals with pathogenic biallelic variants in the MUTYH and NTHL1 genes demonstrate base excision repair tumour mutational signature profiles similar to colorectal cancers, expanding potential diagnostic and variant classification applications
    Article Snippet: Adenoma and CRC tissue DNA and matched blood-derived DNA underwent whole-exome sequencing (WES) using the SureSelect Clinical Research Exome v.2 kit (Agilent Technologies, Santa Clara, CA, United States), to a median depth of 357.9 reads (interquartile range (IQR)=287.8-464.0) for FFPE tissue DNA samples and median depth of 179.1 reads (IQR=118.1-204.6) for blood-derived DNA samples.

    Formalin-fixed Paraffin-Embedded:

    Article Title: Adenomas from individuals with pathogenic biallelic variants in the MUTYH and NTHL1 genes demonstrate base excision repair tumour mutational signature profiles similar to colorectal cancers, expanding potential diagnostic and variant classification applications
    Article Snippet: Adenoma and CRC tissue DNA and matched blood-derived DNA underwent whole-exome sequencing (WES) using the SureSelect Clinical Research Exome v.2 kit (Agilent Technologies, Santa Clara, CA, United States), to a median depth of 357.9 reads (interquartile range (IQR)=287.8-464.0) for FFPE tissue DNA samples and median depth of 179.1 reads (IQR=118.1-204.6) for blood-derived DNA samples.



    Similar Products

    90
    Agilent technologies sureselect clinical research exome v.2 kit
    Sureselect Clinical Research Exome V.2 Kit, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sureselect+clinical+research+exome+v%2E2+kit/med_rxiv__2024__08__08__24311713-27-15-21
    Average 90 stars, based on 1 article reviews
    sureselect clinical research exome v.2 kit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results